Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Sanara MedTech Inc. (SMTI) had Revenue of $23.43M for the most recently reported fiscal quarter, ending 2025-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-03-31

Income Statement Financials
Revenue	$23.43M
Net Income	$-3.53M
Cost of Goods Sold	$1.83M
Gross Profit	$21.60M
Operating Expenses	$25.51M
Operating Income	$-2.08M
Non-Operating Income/Expense	$-1.46M
Pre-Tax Income	$-3.53M
Normalized Pre-Tax Income	$-3.53M
Income after Taxes	$-3.53M
Income from Continuous Operations	$-3.53M
Consolidated Net Income/Loss	$-3.53M
Normalized Income after Taxes	$-3.53M
EBIT	$-2.08M
EBITDA	$-0.90M
Weighted-Average Shares Outstanding (Basic)	8.57M
Weighted-Average Shares Outstanding (Diluted)	8.57M
Earnings per Share (EPS) (Basic)	$-0.41
Earnings per Share (EPS) (Diluted)	$-0.41
Balance Sheet Financials
Current Assets	$36.84M
Property, Plant, and Equipment	$2.06M
Long-Term Assets	$59.54M
Total Assets	$96.38M
Current Liabilities	$13.28M
Long-Term Debt	$43.40M
Long-Term Liabilities	$46.43M
Total Liabilities	$59.71M
Common Equity	$36.67M
Tangible Shareholders Equity	$-8.95M
Shareholders Equity	$36.67M
Common Shares Outstanding	8.90M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-2.00M
Cash Flow from Investing Activities	$-5.18M
Cash Flow from Financial Activities	$11.99M
Beginning Cash	$15.88M
End Cash	$20.69M
Increase/Decrease in Cash	$4.81M
Stock-Based Compensation	$1.30M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.77
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.54
Debt to Equity Ratio	1.18
Gross Margin	92.17%
Operating Margin	-8.88%
EBIT Margin	-8.88%
EBITDA Margin	--
Pre-Tax Profit Margin	-15.05%
Profit Margin	-15.05%
Free Cash Flow	$-3.66M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.24
Inventory Turnover	0.58
Receiveable Turnover	1.97
Days Sales in Receivables	45.72
Return on Equity	-9.62%
Return on Tangible Equity	39.42%
Return on Assets	-3.66%
Return on Investments	-4.41%
Book Value Per Share	$4.12
Free Cash Flow per Share	$-0.43
Operating Cash Flow per Share	$-0.23

Data from Zacks Investment Research, Inc.